As lncRNA XIST loss might induce hematopoietic malignancies and other X-chromosome gene activation events that may cause gene-dosage-associated pathologies in females,20 the application of targeting XIST should be individualized in CRC patients, it might be more feasible in male CRC patients and should be used with caution in female patients. Here, XIST is linked to colorectal carcinoma.